Comparative effectiveness of gliclazide modified release versus sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes

Francesco Zaccardi; Emmanuelle Jacquot; Viviana Cortese; Freya Tyrer; Samuel Seidu; Melanie J. Davies; Kamlesh Khunti

doi:10.1111/dom.14169

Comparative effectiveness of gliclazide modified release versus sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes

Diabetes Obesity and Metabolism ◽

10.1111/dom.14169 ◽

2020 ◽

Vol 22 (12) ◽

pp. 2417-2426

Author(s):

Francesco Zaccardi ◽

Emmanuelle Jacquot ◽

Viviana Cortese ◽

Freya Tyrer ◽

Samuel Seidu ◽

...

Keyword(s):

Type 2 Diabetes ◽

Comparative Effectiveness ◽

Line Treatment ◽

Second Line ◽

Modified Release ◽

Metformin Monotherapy

Review for "Comparative effectiveness of gliclazide modified release vs sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes"

10.1111/dom.14169/v1/review5 ◽

2020 ◽

Author(s):

Tiansheng Wang

Keyword(s):

Type 2 Diabetes ◽

Comparative Effectiveness ◽

Line Treatment ◽

Second Line ◽

Modified Release ◽

Metformin Monotherapy

Review for "Comparative effectiveness of gliclazide modified release vs sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes"

10.1111/dom.14169/v1/review1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Comparative Effectiveness ◽

Line Treatment ◽

Second Line ◽

Modified Release ◽

Metformin Monotherapy

Decision letter for "Comparative effectiveness of gliclazide modified release vs sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes"

10.1111/dom.14169/v3/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Comparative Effectiveness ◽

Line Treatment ◽

Second Line ◽

Modified Release ◽

Metformin Monotherapy

Review for "Comparative effectiveness of gliclazide modified release vs sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes"

10.1111/dom.14169/v2/review2 ◽

2020 ◽

Author(s):

Tiansheng Wang

Keyword(s):

Type 2 Diabetes ◽

Comparative Effectiveness ◽

Line Treatment ◽

Second Line ◽

Modified Release ◽

Metformin Monotherapy

Decision letter for "Comparative effectiveness of gliclazide modified release vs sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes"

10.1111/dom.14169/v2/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Comparative Effectiveness ◽

Line Treatment ◽

Second Line ◽

Modified Release ◽

Metformin Monotherapy

Decision letter for "Comparative effectiveness of gliclazide modified release vs sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes"

10.1111/dom.14169/v1/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Comparative Effectiveness ◽

Line Treatment ◽

Second Line ◽

Modified Release ◽

Metformin Monotherapy

Review for "Comparative effectiveness of gliclazide modified release vs sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes"

10.1111/dom.14169/v2/review3 ◽

2020 ◽

Author(s):

Alanna Weisman

Keyword(s):

Type 2 Diabetes ◽

Comparative Effectiveness ◽

Line Treatment ◽

Second Line ◽

Modified Release ◽

Metformin Monotherapy

Author response for "Comparative effectiveness of gliclazide modified release vs sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes"

10.1111/dom.14169/v2/response1 ◽

2020 ◽

Author(s):

Francesco Zaccardi ◽

Emmanuelle Jacquot ◽

Viviana Cortese ◽

Freya Tyrer ◽

Samuel Seidu ◽

...

Keyword(s):

Type 2 Diabetes ◽

Comparative Effectiveness ◽

Author Response ◽

Line Treatment ◽

Second Line ◽

Modified Release ◽

Metformin Monotherapy

Review for "Comparative effectiveness of gliclazide modified release vs sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes"

10.1111/dom.14169/v1/review3 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Comparative Effectiveness ◽

Line Treatment ◽

Second Line ◽

Modified Release ◽

Metformin Monotherapy

Review for "Comparative effectiveness of gliclazide modified release vs sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes"

10.1111/dom.14169/v1/review2 ◽

2020 ◽

Author(s):

Alanna Weisman

Keyword(s):

Type 2 Diabetes ◽

Comparative Effectiveness ◽

Line Treatment ◽

Second Line ◽

Modified Release ◽

Metformin Monotherapy